Renaissance's biggest holding is its $1.66 billion stake in Bristol-Myers Squibb, a pharmaceuticals giant that makes medicines to treat cancer, HIV/AIDS, cardiovascular disease, diabetes, and other ailments.
Renaissance has a $1.61 billion stake in Chipotle Mexican Grill. The fast-casual Mexican restaurant chain, which has more than 2,500 outlets, has largely recovered from a series of health scares a few years ago.
3. Verisign
3/10
Simons and his team have a $1.56 billion stake in Verisign, a network infrastructure group that operates the registry for domains including .com and .net.
4. Celgene
4/10
Renaissance has amassed a $1.54 billion stake in Celgene, a biotech firm that develops medicines to treat cancers and inflammatory disorders. Celgene is set to be acquired by Bristol Myers-Squibb, the hedge fund's largest holding.
Novo Nordisk is a Danish pharmaceutical company that makes medicines for diabetes, hemophilia, growth disorders, obesity, and other chronic conditions.
Renaissance holds a $1.28 billion stake in the company.
6. Palo Alto Networks
6/10
Renaissance holds a $1.19 billion stake in Palo Alto Networks, a cybersecurity group offering firewalls, network security, cloud-based threat analysis, and other software tools to businesses.
7. Biogen
7/10
Biogen develops treatments for Parkinson's, Alzheimer's, multiple sclerosis, and other neurological diseases. Renaissance has $983 million worth of Biogen shares.
8. Vertex Pharmaceuticals
8/10
Renaissance has a $982 million stake in Vertex Pharmaceuticals, a biotech firm that makes drugs to treat cystic fibrosis, HIV, hepatitis C, cancer, and other ailments.
9. Gilead Sciences
9/10
Gilead Sciences makes antivirus drugs to treat HIV, hepatitis, influenza, and other maladies. Renaissance has a $934 million stake in the biopharmaceuticals group.
Renaissance has amassed $880 million worth of Facebook stock. The social-media titan owns WhatsApp and Instagram as well as Oculus, which makes virtual-reality headsets.